1,4-dimethyl-5-nitro-1H-pyrazole, 1g

1-(4-Hydrazinylphenyl)-N-methylmethanesulfonamide hydrochloride, 95.0%, 25g

2-Piperidinopyridine-4-boronic acid, 95%, 250mg

2,4-Dimethoxyphenylacetic Acid>98.0%(GC)(T)5g

(2-Chloro-4-(trifluoromethoxy)phenyl)boronic acid, 95.0%, 250mg

2-Bromofuran (stabilized with CaO)>98.0%(GC)1g

Propanoic acid, 3-(2-propyn-1-yloxy)-, 2,5-dioxo-1-pyrrolidinyl ester, 98%, 250mg

(7-methyl-2-oxo-2H-chromen-4-yl)acetic acid, 95.0%, 25g

2,3-Dimethyl-4-nitroaniline, 95.0%, 1g

Ethyl 3-(3-(difluoromethyl)-1-methyl-1H-pyrazol-4-yl)-3-oxopropanoate, 95.0%, 250mg

1-(tetrahydro-2H-thiopyran-4-yl)-1H-1,2,3-triazole-4-carboxylic acid, 95.0%, 250mg

2,5-Dimethyl-1,4-phenylenediamine>98.0%(GC)(T)25g

GC capillary column ROTI®Cap-5 MS, 60 m, 0.25 mm, 1.00 µm, 1 Piece(s)